Pages that link to "Q35125938"

The following pages link to Regulation of TMPRSS6 by BMP6 and iron in human cells and mice (Q35125938):

Displaying 49 items.

• Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis (Q21129271) (← links)
• Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review (Q26750731) (← links)
• Hepcidin and iron homeostasis (Q27002595) (← links)
• Mechanisms of mammalian iron homeostasis (Q27010510) (← links)
• The role of TMPRSS6/matriptase-2 in iron regulation and anemia (Q27013874) (← links)
• Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches (Q27027657) (← links)
• Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload? (Q27310179) (← links)
• Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats (Q27323133) (← links)
• Iron regulation by hepcidin (Q28291718) (← links)
• Targeting iron metabolism in drug discovery and delivery (Q33757232) (← links)
• MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription (Q34141088) (← links)
• Inflammation regulates TMPRSS6 expression via STAT5. (Q35077549) (← links)
• Low intracellular iron increases the stability of matriptase-2. (Q35080380) (← links)
• Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis (Q36006369) (← links)
• Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease (Q36142416) (← links)
• Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. (Q36185297) (← links)
• Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage (Q36318716) (← links)
• Progesterone receptor membrane component-1 regulates hepcidin biosynthesis (Q36430759) (← links)
• A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum (Q36579140) (← links)
• Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice. (Q36625078) (← links)
• Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity (Q36631862) (← links)
• A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis (Q36715977) (← links)
• Iron refractory iron deficiency anemia (Q36892562) (← links)
• Identification and characterization of a novel murine allele of Tmprss6. (Q36892568) (← links)
• A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. (Q37000231) (← links)
• Out of balance--systemic iron homeostasis in iron-related disorders (Q37177398) (← links)
• The liver: conductor of systemic iron balance (Q37464105) (← links)
• Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing. (Q38068102) (← links)
• Repulsive guidance molecules (RGMs) and neogenin in bone morphogenetic protein (BMP) signaling (Q38112402) (← links)
• The regulation of iron transport. (Q38153305) (← links)
• Bone morphogenetic proteins as regulators of iron metabolism (Q38226333) (← links)
• Bone Morphogenetic Protein-Based Therapeutic Approaches (Q38733364) (← links)
• Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis (Q38982966) (← links)
• A Red Carpet for Iron Metabolism. (Q39106718) (← links)
• Systemic iron homeostasis and erythropoiesis (Q39226004) (← links)
• The liver in regulation of iron homeostasis (Q39360612) (← links)
• The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice. (Q40146290) (← links)
• Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity. (Q44232479) (← links)
• Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing (Q44320542) (← links)
• Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice. (Q46221935) (← links)
• Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease (Q47745405) (← links)
• Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway (Q47781819) (← links)
• Transcriptome analysis reveals TMPRSS6 isoforms with distinct functionalities. (Q50019778) (← links)
• Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer (Q51015419) (← links)
• Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression. (Q54521300) (← links)
• The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value (Q58577176) (← links)
• Functional diversity of TMPRSS6 isoforms and variants expressed in hepatocellular carcinoma cell lines (Q58722178) (← links)
• The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin (Q90595862) (← links)
• Regulation of Iron Homeostasis and Related Diseases (Q95854712) (← links)